List of Thyquidity drug patents

Thyquidity is owned by Vistapharm.

Thyquidity contains Levothyroxine Sodium.

Thyquidity has a total of 1 drug patent out of which 0 drug patents have expired.

Thyquidity was authorised for market use on 30 November, 2020.

Thyquidity is available in solution;oral dosage forms.

The generics of Thyquidity are possible to be released after 06 August, 2031.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050307 VISTAPHARM Method for the preparation of a levothyroxine solution
Aug, 2031

(8 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 30 November, 2020

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in